0001829126-24-001316.txt : 20240304 0001829126-24-001316.hdr.sgml : 20240304 20240304172515 ACCESSION NUMBER: 0001829126-24-001316 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20240304 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240304 DATE AS OF CHANGE: 20240304 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Zeo ScientifiX, Inc. CENTRAL INDEX KEY: 0001557376 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 474180540 STATE OF INCORPORATION: NV FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-55008 FILM NUMBER: 24716073 BUSINESS ADDRESS: STREET 1: 3321 COLLEGE AVENUE STREET 2: SUITE 246 CITY: DAVIE STATE: FL ZIP: 33314 BUSINESS PHONE: 888-963-7881 MAIL ADDRESS: STREET 1: 3321 COLLEGE AVENUE STREET 2: SUITE 246 CITY: DAVIE STATE: FL ZIP: 33314 FORMER COMPANY: FORMER CONFORMED NAME: Organicell Regenerative Medicine, Inc. DATE OF NAME CHANGE: 20180625 FORMER COMPANY: FORMER CONFORMED NAME: Biotech Products Services & Research, Inc. DATE OF NAME CHANGE: 20150917 FORMER COMPANY: FORMER CONFORMED NAME: BESPOKE TRICYCLES INC DATE OF NAME CHANGE: 20120831 8-K 1 zeoscientifixinc_8k.htm 8-K
false 0001557376 0001557376 2024-03-04 2024-03-04 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): March 4, 2024

 

ZEO SCIENTIFIX, INC.

(Exact name of registrant as specified in its charter)

 

Nevada   000-55008   47-4180540
(State or Other Jurisdiction
of Incorporation)		   (Commission
File Number)		   (IRS Employer
Identification No.)

 

3321 College Avenue, Suite 246

Davie, Florida

   33314
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (888) 963-7881

 

____________________________________________

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each Class   Trading Symbol   Name of each exchange on which registered
None   N/A   N/A

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

As used in this Current Report on Form 8-K (this “Report”), and unless otherwise indicated, the terms “the Company,” “Zeo,” “we,” “us” and “our” refer to Zeo ScientifiX, Inc. f/k/a/ Organicell Regenerative Medicine, Inc. and its subsidiaries.

 

Item 8.01 Other Events.

 

On March 4, 2024, the Company issued a press release announcing that the Financial Industry Regulatory Authority (“FINRA”) had completed the review and processing of the Company’s Issuer Company-Related Action Notification Form, which was submitted to FINRA in connection with the change of our corporate name from “Organicell Regenerative Medicine, Inc.” to “Zeo ScientifiX, Inc.” (which was effective February 20, 2024) and the change in our OTCQB trading symbol from “OCEL” to “ZEOX,” which will be effective with the opening of trading on March 5, 2024.

 

A copy of the press release is attached as Exhibit 99.1 to this Report.

 

Item 9.01 Financial Statements and Exhibits.

 

  (d) Exhibits.

 

Exhibit Number   Description
99.1   Press Release dated March 4, 2024
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: March 4, 2024 ZEO SCIENTIFIX, INC.
     
  By: /s/ Harry Leider
    Harry Leider, M.D.
    Chief Executive Officer

 

2

 EX-99.1 2 zeoscientifix_ex99-1.htm EXHIBIT 99.1

 

Exhibit 99.1

 

 

 

ORGANICELL REGENERATIVE MEDICINE REBRANDING TO ZEO SCIENTIFIX

Leading Therapeutics Research Company Begins New Era

 

Common Stock to trade on OTCQB under the symbol “ZEOX” commencing March 5, 2024

 

Fort Lauderdale, Florida – March 4, 2024 – ZEO ScientifiX, Inc. (OTCQB: ZEOX) (f/k/a Organicell Regenerative Medicine, Inc. – OTCQB: OCEL) today reported that the Financial Industry Regulatory Agency (“FINRA”) completed the processing of the Company’s Corporate Action Notification Form filed with respect to the change of its name from Organicell Regenerative Medicine, Inc. to “ZEO ScientifiX, Inc.” (“ZEO” or the “Company”) and its stock trading symbol from OCEL to “ZEOX” (the “Corporate Action”). The Corporate Action is effective as of the opening of trading, tomorrow, March 5, 2024. In connection with the Corporate Action, the CUSIP number for our common stock will not change.

 

ZEO ScientifiX’s Chief Executive Officer, Harry Leider, MD, MBA commented, “We are delighted about our name change to ZEO as it communicates the energy and creativity inherent in our growing organization. Having recently competed our Phase 1 clinical program, we are eager to move forward to commence and complete our Phase 2 trials, leading us closer to potential FDA approval of our proprietary biologic therapeutics - as well as to continue to grow our flagship product, a first-of-its-kind completely autologous exosome called, Patient Pure X™ (PPX™).”

 

ZEO is a biopharmaceutical company with an R & D program targeted at chronic diseases utilizing novel biological therapeutics. The Company is focused on providing patients access to advanced regenerative therapies as quickly as possible through the rigor of its advanced research programs. The Company recently made several additions to its executive team, adding multiple health care leaders with broad backgrounds in regenerative medicine, commercial healthcare, and the biopharma space.

 

Dr. Leider added, “The progress of our research program and the additions to our leadership team should provide the biotech community with enhanced confidence in ZEO ScientifiX and our future – as we advance to a future where innovative biologic therapeutics will redefine the standard of care for many important chronic diseases.”

 

About ZEO ScientifiX, Inc. 

 

ZEO ScientifiX, Inc.  (OTCQB: ZEOX) is a clinical-stage biopharmaceutical company located inside Nova Southeastern University’s Collaborative Center for Research in Davie, Florida. ZEO is principally focusing on the development of innovative biological therapeutics for the treatment of chronic diseases and the provision of related services. The Company’s proprietary products are derived from allogenic and autologous sources and are manufactured in an FDA-registered, cGMP compliant laboratory to retain the naturally occurring bioactive exosomes, hyaluronic acid, and proteins without the addition or combination of any other substance or diluent.

 

To learn more, please visit https://zeoscientifix.com/

 

 

 

 

Forward-Looking Statements

 

Certain statements contained in this press release, including those regarding its R&D program should be considered forward-looking statements within the meaning of the Securities Act of 1933, as amended (the “Securities Act”), the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the Private Securities Litigation Reform Act of 1995. These forward-looking statements are often identified by the use of forward-looking terminology such as “will,” “believes,” “expects,” “potential,” or similar expressions, involving known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. No assurances can be given that the Company will be successful in its research initiatives. In addition, no assurances can be given that our research initiatives will increase the price of our common stock to a level that is attractive to brokerage houses and institutional investors. We remind you that actual results could vary dramatically as a result of known and unknown risks and uncertainties, including but not limited to: potential issues related to our financial condition, competition, the ability to retain key personnel, product safety, efficacy and acceptance, the commercial success of any new products or technologies, success of clinical programs, ability to retain key customers, our inability to expand sales and distribution channels, legislation or regulations affecting our operations including product pricing, reimbursement or access, the ability to protect our patents and other intellectual property both domestically and internationally, and other known and unknown risks and uncertainties, including the risk factors discussed in the Company’s periodic reports that are filed with the SEC and available on the SEC’s website (http://www.sec.gov). You are cautioned not to place undue reliance on these forward-looking statements. All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these risk factors. Specific information included in this press release may change over time and may or may not be accurate after the date of the release. ZEO has no intention and specifically disclaims any duty to update the information in this press release.

 

Investor Relations and Media Relations Contact

 

ZEO Investor Relations

Jacqueline Domenech

1-888-963-7881
IR@zeoscientifix.com

 

 

 

 GRAPHIC 3 ex99-1_001.jpg GRAPHIC begin 644 ex99-1_001.jpg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
U^"!;N30/%? MAC6=/\3>$]<-C))#%J,.D>)-(TO4+K2YIHK?5;6WFTZXD2"ZD8%%8XBA2Q5" MMAJ\>>CB*4Z-6'-*+E3J1<9)3@XSA)*TH3A*,X3A3J0E&=.$EU8'&XG+<;A, MPP53V.+P.)HXO#57"G44*^'J*I3A6ISHUZL) M_FC\4_\ @I;XC^!/BNZ^&/Q$^#.B>(/'NF226D^J^"_B#?6?A#5)(08_[0B@ MUSP5)K.BI%_@3\$] M939)X3^#*ZUJ/CW7M.::>*\T_7/%^OZ?I)L'G@#6[3:7YNEW$4G^F^'YPC1S M%%?SKPIFV<\9\;\6<)\0YSFF+R#(\1BZ.&P6&Q2RN6+I4,1["%+-<9E5# X[ M,*#C7U]LI*=2,_]!?%'A;A#P?\ !GPM\4^ >$.&&,HXFQV=9)D.(IXA<^$KT\KS:I@5RK".E*C0JT? MMCX(?L[_ E_9Y\.KX=^&/A6UTDRQ(NK^(+H)?>*O$4R'>;G7M=DB2ZO7:0M M(EJGV?3;1F*V-C:Q8C'MU%%?T+@<#@LLPE# Y=A,-@<%AH*GA\+A*-/#X>C! M?9A2I1C%7>LI/FG.3E.I4J3E*:8 HROCL=BZTMYUL3B:E2I*RM"G"/LZ-&G&%*A0P]&G3HTRBBBNL\L__V0$! end EX-101.SCH 4 ocel-20240304.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 5 ocel-20240304_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 ocel-20240304_pre.xml XBRL PRESENTATION FILE XML 7 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Cover
Mar. 04, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Mar. 04, 2024
Entity File Number 000-55008
Entity Registrant Name ZEO SCIENTIFIX, INC.
Entity Central Index Key 0001557376
Entity Tax Identification Number 47-4180540
Entity Incorporation, State or Country Code NV
Entity Address, Address Line One 3321 College Avenue
Entity Address, Address Line Two Suite 246
Entity Address, City or Town Davie
Entity Address, State or Province FL
Entity Address, Postal Zip Code 33314
City Area Code (888)
Local Phone Number 963-7881
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 1 20 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://ocel/role/Cover Cover Cover 1 false false All Reports Book All Reports ocel-20240304.xsd ocel-20240304_lab.xml ocel-20240304_pre.xml zeoscientifixinc_8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "zeoscientifixinc_8k.htm": { "nsprefix": "ocel", "nsuri": "http://ocel/20240304", "dts": { "schema": { "local": [ "ocel-20240304.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "ocel-20240304_lab.xml" ] }, "presentationLink": { "local": [ "ocel-20240304_pre.xml" ] }, "inline": { "local": [ "zeoscientifixinc_8k.htm" ] } }, "keyStandard": 20, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 20 }, "report": { "R1": { "role": "http://ocel/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-03-04", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "zeoscientifixinc_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-04", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "zeoscientifixinc_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://ocel/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 16 0001829126-24-001316-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001829126-24-001316-xbrl.zip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end XML 17 zeoscientifixinc_8k_htm.xml IDEA: XBRL DOCUMENT 0001557376 2024-03-04 2024-03-04 iso4217:USD shares iso4217:USD shares false 0001557376 8-K 2024-03-04 ZEO SCIENTIFIX, INC. NV 000-55008 47-4180540 3321 College Avenue Suite 246 Davie FL 33314 (888) 963-7881 false false false false false